{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:01:33Z","timestamp":1789207293495,"version":"build-2803163510"},"reference-count":141,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1053\/j.seminoncol.2003.08.028","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"763-775","source":"Crossref","is-referenced-by-count":118,"title":["Osteopenia and osteoporosis in women with breast cancer"],"prefix":"10.1053","volume":"30","author":[{"given":"Bhuvaneswari","family":"Ramaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2003.08.028_BIB1","first-page":"584","article-title":"Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice","volume":"45","author":"Osborne","year":"1985","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB2","first-page":"139","article-title":"Sex steroids and breast cancer prevention","volume":"16","author":"Spicer","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","article-title":"Endogenous hormones and breast cancer risk","volume":"15","author":"Bernstein","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1008956524669","article-title":"Menstrual risk factors and early-onset breast cancer","volume":"11","author":"Butler","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women","volume":"94","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","article-title":"Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women","volume":"90","author":"Hankinson","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/1047-2797(94)90105-8","article-title":"Postmenopausal estrogen and the risk of breast cancer","volume":"4","author":"Rossouw","year":"1994","journal-title":"Ann Epidemiol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB8","first-page":"593","article-title":"Postmenopausal estrogen and progestin use in relation to breast cancer risk","volume":"11","author":"Newcomb","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1016330024268","article-title":"Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada","volume":"13","author":"Kirsh","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","article-title":"Prevention of spinal osteoporosis in oophorectomised women","volume":"2","author":"Lindsay","year":"1980","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM199011013231801","article-title":"Spinal bone loss and ovulatory disturbances","volume":"323","author":"Prior","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8588(18)30193-X","article-title":"Bisphosphonates in breast cancer patients with skeletal metastases","volume":"8","author":"Shapiro","year":"1994","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB14","first-page":"63","article-title":"Mechanisms of bone remodeling","volume":"47","author":"Kenny","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s100670170095","article-title":"Osteoprotegerin and osteoprotegerin-ligand balance","volume":"20","author":"Lories","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J Mol Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0531-5565(00)00178-9","article-title":"Molecular control of bone remodeling and osteoporosis","volume":"35","author":"Kong","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D","article-title":"Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin","volume":"92","author":"Hofbauer","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S8756-3282(02)00953-5","article-title":"The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts","volume":"32","author":"Bord","year":"2003","journal-title":"Bone"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.2001.16.8.1416","article-title":"Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones","volume":"16","author":"Ikeda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB21","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/en.140.9.4367","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s001980070028","article-title":"Osteoprotegerin and its ligand","volume":"11","author":"Aubin","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0959-8049(05)80135-2","article-title":"Breast cancer and osteoporosis","volume":"29A","author":"Fentiman","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/33.9.808","article-title":"Bone density of normal women in relation to endogenous and exogenous oestrogens","volume":"33","author":"Fentiman","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199702273360903","article-title":"Bone mass and the risk of breast cancer among postmenopausal women","volume":"336","author":"Zhang","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1053\/j.seminoncol.2003.08.028_BIB26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1289\/ehp.97105s3593","article-title":"Sex steroid hormones, bone mineral density, and risk of breast cancer","volume":"105","author":"Kuller","year":"1997","journal-title":"Environ Health Perspect"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/oxfordjournals.aje.a009554","article-title":"Bone mineral density and risk of breast cancer","volume":"148","author":"Lucas","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(00)00133-X","article-title":"Association between breast cancer and bone mineral density","volume":"36","author":"Nguyen","year":"2000","journal-title":"Maturitas"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0895-4356(00)00301-2","article-title":"Bone mineral density and breast cancer risk in postmenopausal women","volume":"54","author":"Buist","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB30","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.276.17.1404","article-title":"Bone mineral density and risk of breast cancer in older women","volume":"276","author":"Cauley","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jnci\/93.12.930","article-title":"Bone mass and breast cancer risk in older women","volume":"93","author":"Zmuda","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB32","first-page":"22","article-title":"Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort","volume":"2","author":"Nelson","year":"2002","journal-title":"Bio Med Central Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S8756-3282(02)00972-9","article-title":"Bone mineral density and the risk of breast cancer","volume":"32","author":"Van der Klift","year":"2003","journal-title":"Bone"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF01831380","article-title":"Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden)","volume":"5","author":"Persson","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/aje\/153.11.1071","article-title":"Fracture history and risk of breast and endometrial cancer","volume":"153","author":"Newcomb","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00003086-200003000-00016","article-title":"Osteoporosis","volume":"372","author":"Lane","year":"2000","journal-title":"Clin Orthop Rel Res"},{"issue":"suppl 4","key":"10.1053\/j.seminoncol.2003.08.028_BIB37","first-page":"3","article-title":"Osteoporosis","volume":"8","year":"1998","journal-title":"Osteoporosis Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB38","first-page":"1","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"17","year":"2000","journal-title":"NIH Consensus Statement"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB39","doi-asserted-by":"crossref","DOI":"10.1210\/jc.87.6.2460","article-title":"Genetic control of susceptibility to osteoporosis","volume":"87","author":"Ralston","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1179\/acb.2002.052","article-title":"Genetic polymorphisms and clinical practice","volume":"57","author":"Pols","year":"2002","journal-title":"Acta Clin Belg"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1297-319X(01)00311-6","article-title":"The genetics of osteoporosis","volume":"68","author":"Roux","year":"2001","journal-title":"Joint Bone Spine"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB42","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","article-title":"Polychemotherapy for early breast cancer","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/107327480100800108","article-title":"Adjuvant therapy for breast cancer","volume":"8","year":"2001","journal-title":"Cancer Control"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1634\/theoncologist.7-3-246","article-title":"Adjuvant therapy for breast cancer","volume":"7","author":"Mincey","year":"2002","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB45","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2001.19.18.3817","article-title":"Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer: Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer","volume":"19","author":"Goldhirsch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB46","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","article-title":"Side effects of adjuvant treatment of breast cancer","volume":"344","author":"Shapiro","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0015-0282(16)49268-X","article-title":"Prospects for fertility after chemotherapy or radiation for neoplastic disease","volume":"45","author":"Damewood","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB48","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197311292892202","article-title":"Cyclophosphamide-induced ovarian failure","volume":"289","author":"Warne","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB49","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/jwh.1.1999.8.949","article-title":"The risk of premature menopause induced by chemotherapy for early breast cancer","volume":"8","author":"Lower","year":"1999","journal-title":"J Womens Health Gender Based Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB50","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB51","first-page":"125","article-title":"Breast cancer in young women","volume":"16","author":"Reichman","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB52","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB53","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01834642","article-title":"Endocrine profile in breast cancer patients receiving chemotherapy","volume":"20","author":"Mehta","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1097-0142(19830301)51:5<803::AID-CNCR2820510509>3.0.CO;2-V","article-title":"Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients","volume":"51","author":"Dnistrian","year":"1983","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-84-4-389","article-title":"Combination chemotherapy for advanced breast cancer","volume":"84","author":"Canellos","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer","volume":"332","author":"Bonadonna","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB58","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.242.14.1509","article-title":"Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report","volume":"242","author":"Buzdar","year":"1979","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB59","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","article-title":"Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer","volume":"39","author":"Koyama","year":"1977","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB60","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1200\/JCO.1997.15.5.1858","article-title":"Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB61","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1200\/JCO.1999.17.11.3374","article-title":"Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer","volume":"17","author":"Fisher","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","article-title":"Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB63","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","article-title":"Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer","volume":"21","author":"Henderson","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB64","first-page":"A645","article-title":"MHSHC","volume":"76","author":"Fornier","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB65","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650090304","article-title":"Influence of early age at menopause on vertebral bone mass","volume":"9","author":"Pouilles","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1200\/JCO.1999.17.1.130","article-title":"Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer","volume":"17","author":"Chlebowski","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0029-7844(97)00583-8","article-title":"Bone loss in young women with karyotypically normal spontaneous premature ovarian failure","volume":"91","author":"Anasti","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB70","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1200\/JCO.2001.19.14.3303","article-title":"Menopause and breast cancer","volume":"19","author":"Ganz","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB71","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjc.1990.58","article-title":"Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer","volume":"61","author":"Bruning","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer","volume":"15","author":"Delmas","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/90.9.704","article-title":"Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer","volume":"90","author":"Powles","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/07357909809039747","article-title":"Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy","volume":"156","author":"Headley","year":"1998","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB75","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","article-title":"Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients","volume":"37","author":"Vehmanen","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB76","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjc.6690188","article-title":"A high incidence of vertebral fracture in women with breast cancer","volume":"79","author":"Kanis","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB77","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/oxfordjournals.aje.a115730","article-title":"Hip fractures in women with breast cancer","volume":"132","author":"Adami","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-0760(02)00043-2","article-title":"Genetics of osteoporosis","volume":"81","author":"Gennari","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1016048900049","article-title":"Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients","volume":"74","author":"Hou","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1054\/bjoc.2001.1864","article-title":"Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population","volume":"85","author":"Bretherton-Watt","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB81","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO;2-3","article-title":"Association of A vitamin D receptor polymorphism with sporadic breast cancer development","volume":"83","author":"Curran","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1097-0215(20010720)95:4<271::AID-IJC1046>3.0.CO;2-D","article-title":"Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer","volume":"95","author":"Curran","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1634\/theoncologist.5-5-388","article-title":"Raloxifene","volume":"5","author":"Muchmore","year":"2000","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8529(02)00057-9","article-title":"Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis","volume":"32","author":"Fontana","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01806132","article-title":"Effects of anti-estrogens on bone in castrated and intact female rats","volume":"10","author":"Jordan","year":"1987","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB86","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","article-title":"Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats","volume":"122","author":"Turner","year":"1988","journal-title":"Endocrinology"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB87","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02553283","article-title":"The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat","volume":"43","author":"Wakley","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB88","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB89","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/028418698430007","article-title":"Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer","volume":"37","author":"Resch","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB90","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.1994.12.5.992","article-title":"Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients","volume":"12","author":"Kristensen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J013v25n01_03","article-title":"A study of the effects of tamoxifen in the frail elderly","volume":"25","author":"Brewer","year":"1997","journal-title":"Women Health"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB93","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01806160","article-title":"Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen","volume":"39","author":"Kristensen","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB94","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1532-5415.1998.tb02750.x","article-title":"Effect of tamoxifen on bone fractures in older nursing home residents","volume":"46","author":"Breuer","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB95","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer","volume":"90","author":"Fisher","year":"1998","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB96","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00003495-200060020-00013","article-title":"Raloxifene","volume":"60","author":"Clemett","year":"2000","journal-title":"Drugs"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB97","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB98","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jc.87.8.3609","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00002281-200207000-00017","article-title":"Raloxifene","volume":"14","author":"Gluck","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB101","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial: Multiple Outcomes of Raloxifene Evaluation","volume":"28","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2001.tb04011.x","article-title":"The MORE trial: Multiple outcomes for raloxifene evaluation\u2014Breast cancer as a secondary end point: Implications for prevention","volume":"949","author":"Dickler","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB103","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042192-200209000-00012","article-title":"Controversy about uterine effects and safety of SERMs","volume":"9","author":"Goldstein","year":"2002","journal-title":"Menopause"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB104","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1749-6632.2001.tb04027.x","article-title":"The effect of SERMs on the endometrium","volume":"949","author":"Goldstein","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7326\/0003-4819-130-5-199903020-00015","article-title":"Clinical effects of raloxifene hydrochloride in women","volume":"130","author":"Khovidhunkit","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB106","first-page":"25a","article-title":"Effect of raloxifene after tamoxifen on breast and endometrial cancer growth","volume":"21","author":"Regan","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB107","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1185\/0300799019117015","article-title":"Pure antiestrogens and breast cancer","volume":"17","author":"Elkak","year":"2001","journal-title":"Curr Med Res Opin"},{"issue":"suppl 12","key":"10.1053\/j.seminoncol.2003.08.028_BIB108","first-page":"4369s","article-title":"Preliminary experience with pure antiestrogens","volume":"7","author":"Howell","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB109","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.7-6-477","article-title":"FDA drug approval summaries","volume":"7","author":"Bross","year":"2002","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1742-1241.2002.tb11261.x","article-title":"Fulvestrant","volume":"56","author":"Wardley","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB111","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.2002.10.057","article-title":"Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment","volume":"20","author":"Howell","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB112","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1210\/en.139.9.3736","article-title":"Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia","volume":"139","author":"Sibonga","year":"1998","journal-title":"Endocrinology"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB113","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/en.133.6.2787","article-title":"The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats","volume":"133","author":"Gallagher","year":"1993","journal-title":"Endocrinology"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB114","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s002230010092","article-title":"The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats","volume":"66","author":"Turner","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00223-001-2065-z","article-title":"The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model","volume":"70","author":"Vandenput","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB116","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s101470200040","article-title":"The evolving role of aromatase inhibitors in breast cancer","volume":"7","author":"Mokbel","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB117","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","article-title":"Aromatase inhibitors in breast cancer","volume":"348","author":"Smith","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB118","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00045391-200109000-00007","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"8","author":"Brueggemeier","year":"2001","journal-title":"Am J Ther"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0039-128X(99)00104-X","article-title":"Aromatase inhibitors and their application in breast cancer treatment","volume":"65","author":"Brodie","year":"2000","journal-title":"Steroids"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB121","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0960-0760(95)00231-6","article-title":"The control and biological importance of intratumoural aromatase in breast cancer","volume":"56","author":"Dowsett","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB122","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0960-0760(96)00202-6","article-title":"Regulation of aromatase activity within the breast","volume":"61","author":"Miller","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB123","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1023\/A:1006028202087","article-title":"Intratumoral aromatase model","volume":"49","author":"Brodie","year":"1998","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB124","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1023\/A:1006036419833","article-title":"Clinical importance of intratumoral aromatase","volume":"49","author":"Miller","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-0760(01)00050-4","article-title":"Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors","volume":"76","author":"Bhatnagar","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB126","first-page":"1230","article-title":"Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer","volume":"7","author":"Geisler","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB127","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1200\/JCO.20.4.1026","article-title":"Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer","volume":"20","author":"Harper-Wynne","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB128","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB129","first-page":"A633","article-title":"Beneficial side effect profile of anastrozole compared with tamoxifen confirmed by additional 7 months of exposure data","volume":"76","author":"Sainsbury","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 2","key":"10.1053\/j.seminoncol.2003.08.028_BIB130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/107327480200902S01","article-title":"Anti-aromatase agents in the treatment and prevention of breast cancer","volume":"9","author":"Goss","year":"2002","journal-title":"Cancer Control"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB131","first-page":"A132","article-title":"The effects of exemestane on bone and lipid in the ovariectomized rat","volume":"75","author":"Goss","year":"2001","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.08.028_BIB132","first-page":"S107","article-title":"Comparison of the effects of exemestane, 17-hydroexemestane, and letrozole on bone and lipid metabolism in the ovariectomized rat","volume":"76","author":"Goss","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB133","first-page":"2131","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer","volume":"359","author":"Winer","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1745-7599.2001.tb00035.x","article-title":"Bone mineral density in postmenopausal breast cancer survivors","volume":"13","author":"Twiss","year":"2001","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB135","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4065\/75.8.821","article-title":"Prevention and treatment of osteoporosis in women with breast cancer","volume":"75","author":"Mincey","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB136","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5694\/j.1326-5377.2000.tb123917.x","article-title":"Osteoporosis prevention and treatment","volume":"172","author":"Sambrook","year":"2000","journal-title":"Med J Aust"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB137","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3322\/canjclin.49.6.331","article-title":"Goals for nutrition in the year 2000","volume":"49","author":"Willett","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB138","first-page":"293","article-title":"American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis","volume":"7","author":"Hodgson","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB139","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s001980170069","article-title":"The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence","volume":"12","author":"Lunt","year":"2001","journal-title":"Osteoporosis Int"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB140","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.2000.18.6.1378","article-title":"American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.028_BIB141","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","article-title":"Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate","volume":"15","author":"Saarto","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403004780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403004780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:18:12Z","timestamp":1683274692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403004780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0093775403004780"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2003.08.028","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}